Product Highlight - Vicks First Defence

19 May 2022
Product Highlight - Vicks First Defence
Helps to STOP a Cold, when used at 1st signs
• Acts in the first hours/days of infection – when first exposed to risk and/or when 1st sign of minor symptoms is shown1
• Works by first allowing the microgel to TRAP cold viruses in the nasopharynx area2
• The cold viruses trapped in the microgel are then INACTIVATED, reducing its ability to multiple and spread2,3
• Then contributes to a nasal washout effect to REMOVE virus from the nose or down the stomach2
• Clinically proven to reduce cold severity by 60% and duration of cold by 24 days2,4

References:
1. Blaas, D,Fuchs, R.Mechanism of Human Rhinovirus Infections. Mol Cell Pediatr 3,21 (2016).
2. (2005) Satellite symposium. Logopedics phoniatrics Vocology. 30:supl, 41-47.
3. Giranda VL, Heinz BA, Oliveira MA, Minor I, Kim KH, Kolatkar PR, Rossmann MG, Rueckert RR. (1992) Acid - induced structural changes in human rhinovirus 14: possible role in uncoating. Proc Natl Acad Sci USA. 89(21): 10212-17.
4. Hull et.al. Effects of creating a non-specific, virus-hostile environment in the nasopharynx on symptoms and duration of common cold. Acta Otorhinolaryngologica Italica 2007; 27:73-77.

Related MIMS Drugs

Editor's Recommendations